Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

Extramedullary myeloma (EMM) is defined by the presence of plasma cells (PCs) outside
the bone marrow in a patient with multiple myeloma (MM). Using sensitive imaging …

This systematic review of studies compared magnetic resonance imaging (MRI), 18 F‐
fluorodeoxyglucose positron emission tomography (FDG‐PET), FDG‐PET with …

Prognostic implications of 3 imaging tools, metastatic bone survey, magnetic resonance
imaging, and positron emission tomography (PET), were evaluated in 2 consecutive Total …

The role of imaging in myeloma has gained increasing importance over the past few years.
The recently revised definition of myeloma from the International Myeloma Working Group …

Abstract Purpose 18 F-FDG PET/CT has some limitations in the evaluation of multiple
myeloma (MM). Since chemokine receptor-4 is overexpressed in MM, we perform a …

Flurodeoxyglucose Positron Emission Tomography with computed tomography (FDG
PET/CT) and Magnetic Resonance Imaging (MRI) have higher sensitivity and specificity than …

Conventional radiographic skeletal survey has been for many years the gold standard to
detect the occurrence of osteolytic lesions in patients with multiple myeloma (MM). However …

Smoldering multiple myeloma (SMM) bridges the gap between monoclonal gammopathy of
undetermined significance (a mostly premalignant disorder) and active multiple myeloma …

Aim of this prospective study was to assess the sensitivity of positron emission tomography
(PET) and diffusion-weighted imaging (DWI) in detecting multiple myeloma (MM) lesions …